Statement of removal

Autor: Hogea C, Taylor Sm, Van Effelterre Tp

We developed a dynamic compartmental model to assess the impact of HPV Universal Mass Vaccination with Cervarix(®), which offers protection against HPV16/18 and cross-protection against other cancer-causing types, using up-to-date efficacy data. Ana

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f8ffa28c3598143a3c5223912f4da0e4
https://europepmc.org/articles/PMC4975065/

Projected impact of Cervarix™ vaccination on oncogenic human papillomavirus infection and cervical cancer in the United Kingdom.

Autor: Van Effelterre TP; a GSK Vaccines; Global Epidemiology ; Wavre , Belgium., Hogea C; b GSK Vaccines; Global Epidemiology ; King of Prussia , PA USA., Taylor SM; a GSK Vaccines; Global Epidemiology ; Wavre , Belgium.

Publikováno v: Human vaccines & immunotherapeutics [Hum Vaccin Immunother] 2016; Vol. 12 (1), pp. 8-19.